Pharmaceutical rebate contracts, open-house procedure
Original notice title
Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Buyer
Name
IKK classic
Location
Dresden, DEU
Identifier
993-80175-34
Activity
Health
Lots (26)
LOT-0001
Alectinib; ATC-Code: L01ED03
Alectinib; ATC-Code: L01ED03
Location
Duration
Category
Award details
Selection criteria
LOT-0002
Amifampridin; ATC-Code: N07XX05
Amifampridin; ATC-Code: N07XX05
Location
Duration
Category
Award details
Selection criteria
LOT-0003
Bisacodyl; ATC-Code: A06AB02
Bisacodyl; ATC-Code: A06AB02
Location
Duration
Category
Award details
Selection criteria
LOT-0004
Candesartan und Amlodipin; Tabletten; Packungsgröße: 90 Stück; ATC-Code: C09DB07
Candesartan und Amlodipin; Tabletten; Packungsgröße: 90 Stück; ATC-Code: C09DB07
Location
Duration
Category
Award details
Selection criteria
LOT-0005
Clindamycin und Benzoylperoxid; ATC-Code: D10AF54 (ADV), D10AF51 (WHO)
Clindamycin und Benzoylperoxid; ATC-Code: D10AF54 (ADV), D10AF51 (WHO)
Location
Duration
Category
Award details
Selection criteria
LOT-0006
Codein; ATC-Code: R05DA04
Codein; ATC-Code: R05DA04
Location
Duration
Category
Award details
Selection criteria
LOT-0007
Encorafenib; ATC-Code: L01EC03
Encorafenib; ATC-Code: L01EC03
Location
Duration
Category
Award details
Selection criteria
LOT-0008
Fenoterol und Ipratropiumbromid; ATC-Code: R03AL01
Fenoterol und Ipratropiumbromid; ATC-Code: R03AL01
Location
Duration
Category
Award details
Selection criteria
LOT-0009
Glycopyrroniumbromid; ATC-Code: R03BB06
Glycopyrroniumbromid; ATC-Code: R03BB06
Location
Duration
Category
Award details
Selection criteria
LOT-0010
Hydroxycarbamid; 100 mg und 1000 mg; ATC-Code: L01XX05
Hydroxycarbamid; 100 mg und 1000 mg; ATC-Code: L01XX05
Location
Duration
Category
Award details
Selection criteria
LOT-0011
Imiglucerase; ATC-Code: A16AB02
Imiglucerase; ATC-Code: A16AB02
Location
Duration
Category
Award details
Selection criteria
LOT-0012
Interferon beta-1a (Rebif(R)); ATC-Code: L03AB07
Interferon beta-1a (Rebif(R)); ATC-Code: L03AB07
Location
Duration
Category
Award details
Selection criteria
LOT-0013
Lacosamid; Infusionslösung; ATC-Code: N03AX18
Lacosamid; Infusionslösung; ATC-Code: N03AX18
Location
Duration
Category
Award details
Selection criteria
LOT-0014
Moxifloxacin; Augentropfen; ATC-Code: S01AE07
Moxifloxacin; Augentropfen; ATC-Code: S01AE07
Location
Duration
Category
Award details
Selection criteria
LOT-0015
Nintedanib ; ATC-Code: L01EX09
Nintedanib ; ATC-Code: L01EX09
Location
Duration
Category
Award details
Selection criteria
LOT-0016
Ribociclib; ATC-Code: L01EF02
Ribociclib; ATC-Code: L01EF02
Location
Duration
Category
Award details
Selection criteria
LOT-0017
Romiplostim; ATC-Code: B02BX04
Romiplostim; ATC-Code: B02BX04
Location
Duration
Category
Award details
Selection criteria
LOT-0018
Rufinamid; ATC-Code: N03AF03
Rufinamid; ATC-Code: N03AF03
Location
Duration
Category
Award details
Selection criteria
LOT-0019
Sirolimus; ATC-Code: L04AH01
Sirolimus; ATC-Code: L04AH01
Location
Duration
Category
Award details
Selection criteria
LOT-0020
Tafamidis; ATC-Code: N07XX08
Tafamidis; ATC-Code: N07XX08
Location
Duration
Category
Award details
Selection criteria
LOT-0021
Triptorelin; ATC-Code: L02AE04
Triptorelin; ATC-Code: L02AE04
Location
Duration
Category
Award details
Selection criteria
LOT-0022
Eculizumab; ATC-Code: L04AJ01
Eculizumab; ATC-Code: L04AJ01
Location
Duration
Category
Award details
Selection criteria
LOT-0023
Caspofungin; ATC-Code: J02AX04
Caspofungin; ATC-Code: J02AX04
Location
Duration
Category
Award details
Selection criteria
LOT-0024
Folsäure; ATC-Code: B03BB01
Folsäure; ATC-Code: B03BB01
Location
Duration
Category
Award details
Selection criteria
LOT-0025
Levomethadon; ATC-Code: N07BC05
Levomethadon; ATC-Code: N07BC05
Location
Duration
Category
Award details
Selection criteria
LOT-0026
Salmeterol und Fluticason; Inhalationspulver; ATC-Code: R03AK06
Salmeterol und Fluticason; Inhalationspulver; ATC-Code: R03AK06
Location
Duration
Category
Award details
Selection criteria
Procurement Details
- Publication date
- 19 Apr 2026
- Notice type
- Contract notice — standard
- Languages
- German
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 266413-2026
Documents (1)
Similar tenders
Sweden – Repair and maintenance services – Hisservice Södra Sverige, ramavtal
Germany – Construction work for school buildings – 302-01 Baumeisterarbeiten | Erweiterung und Generalsanierung Realschule Thannhausen
Poland – Engineering services – Wykonanie kompleksowej, wielobranżowej dokumentacji projektowej dla inwestycji pn.: Rozbudowa Estakady Kwiatkowskiego w Gdyni
France – Architectural services for outdoor areas – Mission de maîtrise d'oeuvre pour la construction d'une télécabine entre Bozel - Saint-Bon - Courchevel Village
Switzerland – Building construction work – BAV 59016 Recyclingzentrum Juch-Areal, Neubau Juch-Areal - BKP 214 Montagebau in Holz
Switzerland – Architectural, engineering and planning services – Zukunftfähiges OT-RZ
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications